โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost

Sponsored by Westlake Eye Specialists

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...

Current Status

Completed

Auto-verified from ClinicalTrials.gov

Verified Oct 22, 2025

Phase

Clinical Trial

Sponsor

Westlake Eye Specialists

Enrollment Target

100

Start Date

Jun 2024

๐Ÿ“Š
1 of 100 participants interested
1% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

A randomized, multicenter, investigator-masked prospective study of NTG patients currently on latanoprost 0.005% monotherapy, to study the effect of IOP change with the introduction of netarsudil 0.02% vs brimonidine 0.1%. Subjects will be assessed at a screening visit, and 1 follow-up visit. Clinical evaluations will include visual acuity and IOP .

Who Can Participate

Inclusion Criteria

Patients 18 years and older
Diagnosed with normal tension glaucoma based on the following:
IOP โ‰ค 21mmHg
Optic nerve rim thinning and/or retinal nerve fiber layer (RNFL) loss consistent with glaucoma
Normal visual field OR visual field loss consistent with optic nerve or RNFL defects within the last year
Open angles assessed by gonioscopy
Have been on latanoprost monotherapy for at least 6 weeks

Exclusion Criteria

If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study.
Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
Other forms of secondary glaucoma.
Patients with abnormal anterior segment examination other than cataract will be excluded from the study.
Patients who have had incisional surgery for glaucoma (eg: MIG

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

100 participants

โšง

Gender

ALL

๐Ÿข

Sponsor

Westlake Eye Specialists

Study Locations

Choose your preferred location or select flexible during enrollment

Unknown

Austin

Texas

Location available
View Austin location page
Unknown

Killeen

Texas

Location available
View Killeen location page
Unknown

Kyle

Texas

Location available
View Kyle location page
Unknown

New Braunfels

Texas

Location available
View New Braunfels location page

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Find More Ulcerative Colitis Trials by City

Browse all ulcerative colitis clinical trials in these cities โ€” not just this study.

Looking for Glaucoma Treatment in Austin?

Join others in Texas exploring innovative treatment options through clinical research

Glaucoma Treatment Options in Austin, Texas

If you're searching for Glaucoma treatment in Austin, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Austin, Killeen, Kyle and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Glaucoma. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Texas
Now Enrolling
Up to 100 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Glaucoma?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Glaucoma

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Glaucoma Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06449352. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.